Menu

2021 AONN+ Midyear Virtual Conference Agenda

Wednesday, May 12

12:00 pm – 4:00 pm ET
Preconference Workshop | Prehab/Rehab

Read Overview

Preconference Workshop | Prehab/Rehab

Description:

Prehabilitation is an evidence-based process that occurs in the time between diagnosis and the start of acute care. Cancer rehabilitation deals with helping patients overcome side effects that may occur due to chemotherapy treatment. This panel discussion will discuss how your patient’s quality of life can be improved through these processes.

Objectives:

Upon completion of the session, participants will be able to:

  • Discuss the difference between cancer prehabilitation and cancer rehabilitation
  • Discuss how to develop a prehab and rehab program
  • Discuss how prehab and rehab can strengthen you cancer care program and meet the survivorship requirement of the commission on cancer
12:00 pm – 4:00 pm ET
Preconference Workshop | The Nuts and Bolts of Building a Navigation Program

Read Overview

Preconference Workshop | The Nuts and Bolts of Building a Navigation Program

Description:

What makes a successful navigation program? Learn from seasoned navigation leaders as they share real-world knowledge impacting the build of a thriving navigation program. Focused discussion centered on program build and implementation, metrics and outcomes, navigation role and scope, and effective communication strategies will equip the participant with seasoned learnings to build a sustainable navigation program.

Participants will have an opportunity to roll up their sleeves and partner with navigation leaders representing a variety of navigation models to ask questions and gain insights into current challenges facing navigators as you work to build and sustain successful navigation programs. Participants will gain new ideas and strategies to apply to their current experience.

Objectives:

Upon completion of the session, participants will be able to:

  • Explore best practices and real-world knowledge with a panel of navigation leaders to build a sustainable navigation program
  • Discover how to identify and utilize metrics and outcomes to evaluate a navigation program
  • Define navigation scope and responsibilities for the licensed and unlicensed navigator to build a collaborative team and program
  • Gain insight into effective communication strategies to promote the value of navigation with stakeholders such as patients, physicians, administrators, and colleagues

Thursday, May 13

8:30 am – 9:00 am ET
Welcome and Opening Remarks
9:00 am – 10:15 am ET
General Session 1 | Smoking Cessation

Read Overview

General Session 1 | Smoking Cessation

Description:

This presentation will discuss the current state of tobacco use in the United States, including how e-cigarettes factor into the smoking picture. Smoking cessation strategies from a multidisciplinary perspective will be addressed, to help navigators support their patients/community in this process. Both pharmacologic and nonpharmacologic interventions will be reviewed, with the ultimate goal of preventing relapse.

Objectives:

Upon completion of the session, participants will be able to:

  • Discuss the current state of tobacco use in the United States and its impact on cancer risk
  • List at least 3 smoking cessation strategies that navigators can facilitate to support their patients
  • Describe at least 3 factors important to preventing relapse
10:15 am – 11:30 am ET
General Session 2 | Making a Business Case for Financial Navigation

Read Overview

General Session 2 | Making a Business Case for Financial Navigation

Description:

This presentation will discuss the business of developing a financial navigation program. Many navigators/administrators ask about how they can get financial navigators. Many programs have nurses and social workers who are providing financial navigation in addition to the services they regularly provide.

11:30 am – 12:45 pm ET
General Session 3 | Leveraging Technology to Enhance Navigator Workflow and Metrics Collection

Read Overview

General Session 3 | Leveraging Technology to Enhance Navigator Workflow and Metrics Collection

Description:

This session will explore EMR capabilities for tracking navigation workflow and metrics (pros, cons). It will discuss the challenges and successes in using the EMR to enhance navigator workflow (eg, workflow, team communication, metrics collection, quality improvement initiatives). It will also share best practice examples using the PDSA model to illustrate how to initiate change.

12:45 pm – 2:00 pm ET
Industry Sponsored Session | Janssen
ERLEADA®: For the Treatment of Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) and Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC)
2:00 pm – 3:15 pm ET
General Session 4 | Taking Your Financial Navigation to the Next Level
3:15 pm – 4:30 pm ET
General Session 5 | Geriatric Oncology

Read Overview

General Session 5 | Geriatric Oncology

Description:

This session will provide an overview of ageism and other discrimination in healthcare, using cancer care to create clinically relevant illustration and case studies, and offers solutions in person-centered, age-friendly models of care. The session will include definitions of major concepts and ways to integrate these concepts into clinical practice on a daily basis. Goals of person-centered, age-friendly care will be described in relation to national and international initiatives with clinical pearls and tips outlined to make changing practice a reality for each participant.

Objectives:

Upon completion of the session, participants will be able to:

  • Define ageism, listing 2 forms of this form of discrimination beyond negative or “elder bashing” ageism
  • Describe how ageism combines with other forms of discrimination to lessen the healthcare experience and outcome quality
  • Identify 3 strategies to help overcome ageism and intersecting forms of discrimination in healthcare for individuals and families

Friday, May 14

9:15 am – 10:15 am ET
Attendee Networking Session
10:15 am – 12:15 pm ET
Exhibit Hall Open
10:30 am – 11:30 am ET
Industry Sponsored Session | Bristol-Myers Squibb
Treatment of Patients in Newly Diagnosed Multiple Myeloma: Patient Adherence and Dose Modifications in Response to Adverse Events
12:30 pm – 1:30 pm ET
Industry Sponsored Session | Exelixis
RCC APP: Clinical Management of 1L Advanced RCC Patients on CABOMETYX® + OPDIVO®
1:30 pm – 2:45 pm ET
General Session 6 | Tumor Board Format You can’t make this stuff up.
2:45 pm – 3:45 pm ET
Breakout Session 1 | Caring for the Caregiver

Read Overview

Breakout Session 1 | Caring for the Caregiver

Objectives:

Upon completion of the session, participants will be able to:

  • Explore compassion fatigue sources, signs, and impact
  • Adopt a positive and proactive approach for self-care
  • Exchange experiences and best practices in coping with compassion fatigue
2:45 pm – 3:45 pm ET
Breakout Session 2 | Screening in the COVID Era

Read Overview

Breakout Session 2 | Screening in the COVID Era

Description:

Fewer adults are undergoing routine preventive healthcare and cancer screening during the COVID-19 pandemic, leading to missed and delayed cancer diagnoses. In this session, presenters will address cancer screening rates during the pandemic and the role oncology navigators can play to support patients as they seek preventive care.

Objectives:

Upon completion of the session, participants will be able to:

  • Address the decline in cancer screening rates as a result of the COVID-19 pandemic
  • Discuss the opportunities navigators provide to assist patients to ensure they are seeking timely and appropriate early detection and screening
2:45 pm – 3:45 pm ET
Breakout Session 3 | Prepping Your Professional Image
2:45 pm – 3:45 pm ET
Breakout Session 4 | Lack of Support for Patients Living with Chronic/Metastatic Disease
3:45 pm – 6:00 pm ET
Exhibit Hall Open
4:00 pm – 5:00 pm ET
Industry Sponsored Session | Regeneron
Harnessing the Power of Immunity

Saturday, May 15

8:45 am – 9:45 am ET
General Session 7 | Understanding the Needs of the AYA Population

Read Overview

General Session 7 | Understanding the Needs of the AYA Population

Description:

This session will include a 30-year-old patient with Ewing’s sarcoma, his spouse, an oncology nurse navigator and oncology social worker narrating his journey over the past 9 years and living with metastatic cancer. This session will discuss the unique treatment and adjustment needs that require patient-centered care involving a multidisciplinary team from a patient perspective. Age-related, developmental challenges, including independence, navigating college, career, relationships, fertility and family planning, and psychosocial support needs, will be identified. Participants will gain an understanding of the barriers and challenges of accessing clinical trials for the AYA patient.

Objectives:

Upon completion of the session, participants will be able to:

  • Identify the multidisciplinary team members involved in caring for the AYA patient
  • Describe age-related, developmental challenges of the AYA patient
  • Define psychosocial support needs of the AYA patient
  • Identify barriers and challenges of clinical trial access for the AYA patient
9:45 am – 11:45 am ET
Exhibit Hall Open
10:00 am – 11:00 am ET
Industry Sponsored Session | Incyte
Intervening with Jakafi® (ruxolitinib) to Achieve Durable Count Control: Real-World Patient Case Discussion | Focus on Adults with Polycythemia Vera Who Have an Inadequate Response to Hydroxyurea
12:00 pm – 1:00 pm ET
Industry Sponsored Session | Merck
A Treatment Option for Patients with Certain Types of Advanced TNBC
1:00 pm – 2:15 pm ET
Breakout Session 5 | Caring for the Caregiver
1:00 pm – 2:15 pm ET
Breakout Session 6 | Screening in the COVID Era

Read Overview

Breakout Session 6 | Screening in the COVID Era

Description:

Fewer adults are undergoing routine preventive healthcare and cancer screening during the COVID-19 pandemic, leading to missed and delayed cancer diagnoses. In this session, presenters will address cancer screening rates during the pandemic and the role oncology navigators can play to support patients as they seek preventive care.

Objectives:

Upon completion of the session, participants will be able to:

  • Address the decline in cancer screening rates as a result of the COVID-19 pandemic
  • Discuss the opportunities navigators provide to assist patients to ensure they are seeking timely and appropriate early detection and screening
1:00 pm – 2:15 pm ET
Breakout Session 7 | Prepping Your Professional Image
1:00 pm – 2:15 pm ET
Breakout Session 8 | Lack of Support for Patients Living with Chronic/Metastatic Disease
2:15 pm – 4:30 pm ET
Exhibit Hall Open
2:15 pm – 3:15 pm ET
Industry Sponsored Session | Lilly
A CDK4 & 6 Inhibitor with Overall Survival Data
4:30 pm – 6:00 pm ET
Dying is Not Giving Up
6:00 pm – 7:00 pm ET
Attendee Networking Session

Sunday, May 16

9:15 am – 10:30 am ET
General Session 8 | End-of-Life Session
10:30 am – 12:00 pm ET
General Session 9 | Powerful Conversations with Your Oncology Colleagues

Read Overview

General Session 9 | Powerful Conversations with Your Oncology Colleagues

Description:

Successful navigators need to know how to address difficult workplace disagreements with their various healthcare teams. This session will help navigators learn the skills to effectively overcome colleague disagreements, while strengthening workplace collaboration and better care for the oncology patient.

Objectives:

Upon completion of the session, participants will be able to learn immediately applicable skills for addressing difficult workplace disagreements while preserving relationships, including how to:

  • Show up as your best self
  • Address the real issues
  • Manage “unhelpful” reactions
  • Work toward common solutions
12:00 pm ET
Closing Remarks

Thank You to Our Corporate Sponsors and Alliance Partners!

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • Health System Partner

    Health System Partner

  • Health System Partner

    Health System Partner

  • Health System Partner

    Health System Partner